Malignant Neoplasms of Independent (Primary) Multiple Sites
11
1
3
5
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 11 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (11)
Expectations Regarding Mobility and Self-Care
Pembrolizumab With Intratumoral Injection of Clostridium Novyi-NT
Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases
Communication Strategies to Introduce Psychology Services
Chronic Non-Malignant Pain in Cancer Patients at a Supportive Care Clinic
The Effect of Yogurt in Cancer Patient With Moderate Gastrointestinal (GI) Symptoms
Wearable Exercise Trackers in Cancer Rehabilitation
Patient Perception of Physician's Compassion, Communication Skills, and Professionalism During an Outpatient Palliative Care Visit
Effect of Physician Attire on Patients' Preference of Physician
Difference in the Estimation of Prognosis
Lenvatinib and Capecitabine in Patients With Advanced Malignancies